Published tirzepatide weekly titration chart compiled for Australia research reference, including reconstitution math at common vial strengths.
This chart is a research-reference compilation of the weekly tirzepatide titration schedule used in published clinical trial protocols. It is intended for analytical and laboratory documentation only.
| Week | Reference Dose | Volume @ 5 mg/mL | Volume @ 10 mg/mL |
|---|---|---|---|
| 1–4 | 2.5 mg | 0.50 mL | 0.25 mL |
| 5–8 | 5 mg | 1.00 mL | 0.50 mL |
| 9–12 | 7.5 mg | 1.50 mL | 0.75 mL |
| 13–16 | 10 mg | 2.00 mL | 1.00 mL |
| 17–20 | 12.5 mg | 2.50 mL | 1.25 mL |
| 21+ | 15 mg | 3.00 mL | 1.50 mL |
Reconstitution math is provided for analytical reference only.
Research use only. 3 Diamond Labs supplies materials strictly for in vitro and laboratory research. Nothing in this article constitutes medical, therapeutic, or dosage advice for human or animal use.
